HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

WEHI-916

an inhibitor of plasmepsin V, an aspartyl protease isolated from Plasmodium falciparum; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - WEHI-916: 1
Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - WEHI-916: 1
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - WEHI-916: 1

Experts

1.	Kumar, Sushil: 1 article (05/2015)
2.	Kumari, Renu: 1 article (05/2015)
3.	Pandey, Richa: 1 article (05/2015)

Related Diseases

1.

05/01/2015 - "Some of the putative next-generation antimalarials that possess in their scaffold structure several of the desired properties of malaria cure and control are exemplified by OZ439, NITD609, ELQ300 and tafenoquine that are already undergoing clinical trials, and decoquinate, usnic acid, torin-2, ferroquine, WEHI-916, MMV396749 and benzothiophene-type N-myristoyltransferase (NMT) inhibitors, which are candidates for future clinical usage. "

Related Drugs and Biologics

1.	Decoquinate
2.	Antimalarials (Antimalarial Agents)
3.	NITD 609
4.	ferroquine
5.	benzothiophene
6.	usnic acid
7.	tafenoquine
8.	glycylpeptide N-tetradecanoyltransferase